Ilika plc with ticker (LON:IKA) now has a potential upside of 197.3% according to Berenberg Bank.
Berenberg Bank set a target price of 110 GBX for the company, which when compared to the Ilika plc share price of 37 GBX at opening today (31/01/2024) indicates a potential upside of 197.3%. Trading has ranged between 25 (52 week low) and 72 (52 week high) with an average of 227,582 shares exchanging hands daily. The market capitalisation at the time of writing is £58,820,972.
Ilika plc is a United Kingdom-based company. The Company is engaged in developing and commercializing its cutting-edge solid-state batteries. The Company develops and commercializes its thin-film Stereax miniature solid-state batteries for powering implantable medical devices and industrial wireless sensors (IIoT) in specialist environments, as well as progressing the development of its large-format Goliath cells for electric vehicles (EV) and cordless appliances. It has a secured lease of approximately 1,600 square meters property for Stereax manufacturing scale-up and installed over 340 square meters clean room facility. The Company is enabling solutions for applications, such as industrial Internet of things (IoT), MedTech, electric vehicles (EV) and consumer electronics. The Company has its operations in the United States of America, China and Israel.
Ilika plc 197.3% potential upside indicated by Berenberg Bank
- Written by: Charlotte Edwards
Find more news, interviews, share price & company profile here for:
Latest Company News
UK solid-state battery developer Ilika is progressing from pilot production to commercial validation in next-generation battery technology.
Ilika will present its solid-state battery capabilities at The Battery Show Europe 2026 as it strengthens engagement with Europe’s battery manufacturing ecosystem.
Ilika announces that CEO Graeme Purdy and CFO Jason Stewart will present at the Yellowstone Advisory Private Investor evening on 25 February 2026 at Hudson Sandler, London.
These ten AIM-quoted ESG stocks offer investors exposure to companies where commercial progress and responsible business practices go hand in hand.
Ilika begins commercial delivery of Stereax electrodes under first supply order from Cirtec.
Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.
